Pharma Block Sciences (Nanjing) (SZSE:300725) Other Income (Minority Interest) : ¥0 Mil (TTM As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Pharma Block Sciences (Nanjing) Other Income (Minority Interest)?

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary. Pharma Block Sciences (Nanjing)'s Other Income (Minority Interest) for the three months ended in Sep. 2024 was ¥0 Mil. Its Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0 Mil.

Pharma Block Sciences (Nanjing) Other Income (Minority Interest) Historical Data

The historical data trend for Pharma Block Sciences (Nanjing)'s Other Income (Minority Interest) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Block Sciences (Nanjing) Other Income (Minority Interest) Chart

Pharma Block Sciences (Nanjing) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Income (Minority Interest)

Get a 7-Day Free Trial

-17.21

-11.67

Pharma Block Sciences (Nanjing) Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Income (Minority Interest)	Get a 7-Day Free Trial															-	-	-	-	-

Pharma Block Sciences (Nanjing) Other Income (Minority Interest) Calculation

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary.

Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Pharma Block Sciences (Nanjing) (SZSE:300725) Other Income (Minority Interest) Explanation

Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company. It is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Pharma Block Sciences (Nanjing) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharma Block Sciences (Nanjing) Inc (SZSE:300725) » Definitions » Other Income (Minority Interest)

Traded in Other Exchanges

N/A

Address

10 Xuefu Road, Nanjing High-tech Industrial Development Zone, Jiangsu, Nanjing, 210032, CHN, 210032

Website

http://www.pharmablock.com

Pharma Block Sciences (Nanjing) Inc is a chemistry products and services provider through the pharmaceutical research and development process. Its core business activities include pilot plant and commercial manufacturing of key intermediates and active pharmaceutical ingredient, process development, custom synthesis and building blocks.

Executives

Yang Min Min	Directors, executives
	Directors, executives
Chen La Mei	Executives
Wu Xi Han	Director
	Executives
	Directors, executives
Luo Fei	Supervisors

Pharma Block Sciences (Nanjing) Headlines

No Headlines